Economic Effects of Government Shutdown, and More from CRS
New and updated reports from the Congressional Research Service that Congress has withheld from online public distribution include the following.
The FY2014 Government Shutdown: Economic Effects, November 1, 2013
Legislative Actions to Repeal, Defund, or Delay the Affordable Care Act, October 30, 2013
Membership of the 113th Congress: A Profile, October 31, 2013
Salaries of Members of Congress: Recent Actions and Historical Tables, November 4, 2013
Salaries of Members of Congress: Congressional Votes, 1990-2013, November 4, 2013
Women in the United States Congress: Historical Overview, Tables, and Discussion, September 26, 2013
Women in the United States Congress, 1917-2013: Biographical and Committee Assignment Information, and Listings by State and Congress, September 26, 2013
Burma’s Political Prisoners and U.S. Sanctions, October 30, 2013
Cuba: U.S. Restrictions on Travel and Remittances, November 1, 2013
Israel: Background and U.S. Relations, November 1, 2013
Iran: U.S. Concerns and Policy Responses, November 4, 2013
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.